Literature DB >> 1708892

An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice.

S Runkel1, N Hunter, L Milas.   

Abstract

A method is reported for the study of early phases of neovascularization in syngeneic murine tumors and human tumor xenografts in nude mice. Using this method, the effect of irradiation of tumor cells or tumor bed on tumor angiogenesis was studied. Tumor cells were injected intradermally in the abdominal skin flap, which was reopened at 2-day intervals to quantify newly formed blood vessels at the site of tumor cell injection. Both tumor cell injection and blood vessel counting were performed under a dissecting microscope. Using three syngeneic murine tumors and two clones of a human colonic adenocarcinoma, it was observed that new blood vessels started appearing within a few days after tumor cell injection and that this event preceded measurable tumor growth. The number of blood vessels increased exponentially for several days but then their further growth slowed. The extent of angiogenesis depended on the tumor type and the number of tumor cells injected. The exposure of the skin flap to ionizing radiation prior to tumor cell injection reduced neovascularization. We further observed that heavily irradiated tumor cells retained their ability to induce angiogenic response and that lymphoid cells (peritoneal exudate and spleen cells) could also elicit an angiogenic response, although it is weaker than the response elicited by tumor cells. Thus this method is suitable for quantification and kinetics of early phases of tumor angiogenesis in individual mice bearing transplants of syngeneic tumors or human tumor xenografts, and it can be useful for investigating various regulators of tumor angiogenesis.

Entities:  

Mesh:

Year:  1991        PMID: 1708892

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  4 in total

1.  Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.

Authors:  Olaf Penack; Erik Henke; David Suh; Chris G King; Odette M Smith; Il-Kang Na; Amanda M Holland; Arnab Ghosh; Sydney X Lu; Robert R Jenq; Chen Liu; George F Murphy; Theresa T Lu; Chad May; David A Scheinberg; Ding Cheng Gao; Vivek Mittal; Glenn Heller; Robert Benezra; Marcel R M van den Brink
Journal:  J Natl Cancer Inst       Date:  2010-05-12       Impact factor: 13.506

2.  Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma.

Authors:  E K Rofstad; T Danielsen
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

3.  Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).

Authors:  Dietmar W Siemann; Christina M Norris; Anderson Ryan; Wenyin Shi
Journal:  Anticancer Res       Date:  2009-06       Impact factor: 2.480

4.  Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern.

Authors:  E K Rofstad
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.